Healthcare provider profile · identity verified

John David Pelfrey, M.D.

Family Practice · DUBLIN, OH · NPI 1609895390

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	582	158
Amlodipine Besylate	Amlodipine Besylate	361	102
Telmisartan	Telmisartan	341	87
Levothyroxine Sodium	Levothyroxine Sodium	328	88
Lisinopril	Lisinopril	221	66
Pantoprazole Sodium	Pantoprazole Sodium	189	54
Metoprolol Succinate	Metoprolol Succinate	161	54
Trazodone Hcl	Trazodone Hcl	157	41
Omeprazole	Omeprazole	156	48
Prednisone	Prednisone	152	111
Hydrochlorothiazide	Hydrochlorothiazide	147	43
Simvastatin	Simvastatin	147	41
Valsartan	Valsartan	138	34
Synthroid	Levothyroxine Sodium	130	28
Gabapentin	Gabapentin	116	34
Alprazolam	Alprazolam	114	31
Eliquis	Apixaban	107	21
Fluoxetine Hcl	Fluoxetine Hcl	95	21
Rosuvastatin Calcium	Rosuvastatin Calcium	91	25
Metformin Hcl Er	Metformin Hcl	88	25
Allopurinol	Allopurinol	87	24
Metformin Hcl	Metformin Hcl	87	29
Bupropion Xl	Bupropion Hcl	84	21
Azithromycin	Azithromycin	83	74
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	83	35
Losartan Potassium	Losartan Potassium	75	23
Tramadol Hcl	Tramadol Hcl	73	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	72	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	72	17
Albuterol Sulfate Hfa	Albuterol Sulfate	71	27
Escitalopram Oxalate	Escitalopram Oxalate	70	19
Doxycycline Hyclate	Doxycycline Hyclate	68	45
Sertraline Hcl	Sertraline Hcl	67	17
Atenolol	Atenolol	65	19
Oxycodone Hcl	Oxycodone Hcl	65	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	64	45
Lorazepam	Lorazepam	63	16
Glipizide	Glipizide	62	20
Montelukast Sodium	Montelukast Sodium	62	18
Furosemide	Furosemide	59	20
Clopidogrel	Clopidogrel Bisulfate	56	16
Fluconazole	Fluconazole	56	23
Tamsulosin Hcl	Tamsulosin Hcl	56	22
Zolpidem Tartrate	Zolpidem Tartrate	48	12
Cefuroxime	Cefuroxime Axetil	47	39
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	47	35
Buspirone Hcl	Buspirone Hcl	45	16
Fluticasone Propionate	Fluticasone Propionate	45	15
Metoprolol Tartrate	Metoprolol Tartrate	44	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	16
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	41	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	11
Citalopram Hbr	Citalopram Hydrobromide	37	11
Xarelto	Rivaroxaban	36	suppressed
Ketoconazole	Ketoconazole	34	16
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Terazosin Hcl	Terazosin Hcl	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Amoxicillin	Amoxicillin	32	27
Warfarin Sodium	Warfarin Sodium	30	suppressed
Acyclovir	Acyclovir	29	12
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Meloxicam	Meloxicam	28	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Carvedilol	Carvedilol	26	suppressed
Adderall Xr	Dextroamphetamine/Amphetamine	25	suppressed
Etodolac	Etodolac	23	suppressed
Hydrocortisone	Hydrocortisone	23	11
Promethazine Hcl	Promethazine Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	16
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Naproxen	Naproxen	20	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	17
Potassium Chloride	Potassium Chloride	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Testosterone	Testosterone	19	suppressed
Levofloxacin	Levofloxacin	18	12
Nifedipine Er	Nifedipine	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	11
Ozempic	Semaglutide	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Cephalexin	Cephalexin	14	12
Donepezil Hcl	Donepezil Hcl	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Methylphenidate Er	Methylphenidate Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Linzess	Linaclotide	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error